```html

Infectious Keratitis – A Comprehensive Patient Guide

Overview

Keratitis is inflammation of the cornea, the clear front surface of the eye. When the inflammation is caused by bacteria, viruses, fungi, or parasites, it is termed **infectious keratitis**. The condition can develop rapidly, leading to pain, vision loss, and, in severe cases, permanent blindness.

Anyone can develop infectious keratitis, but certain groups are disproportionately affected:

• Contact‑lens wearers – especially those who sleep in lenses or use poor hygiene.
• Athletes or outdoor workers exposed to soil, plant material, or contaminated water.
• Individuals with ocular surface disease (dry eye, blepharitis) or a history of eye trauma.
• People with weakened immune systems (e.g., diabetes, HIV, patients on systemic steroids).

In the United States, the incidence of contact‑lens‑associated keratitis is estimated at **4–6 cases per 10,000 lens users per year** (CDC, 2022). Worldwide, infectious keratitis is a leading cause of corneal blindness, accounting for **~2 million new cases annually** (WHO, 2021).

Symptoms

Symptoms often appear within hours to a few days after the cornea is exposed to a pathogen. Seek evaluation promptly if you notice any of the following:

• Eye pain or discomfort – varies from mild irritation to severe throbbing.
• Redness – usually around the white of the eye (sclera) and the limbus (border of cornea).
• Blurred or decreased vision – may fluctuate.
• Photophobia – heightened sensitivity to light.
• Tearing or discharge – clear watery tears or purulent (pus‑filled) discharge.
• Foreign‑body sensation – feeling like something is in the eye.
• Swelling of the eyelids (blepharitis) or conjunctiva.
• Ulceration visible on the cornea – a white or gray spot that may have a surrounding halo.

Causes and Risk Factors

Microbial agents

• Bacterial – most common are Pseudomonas aeruginosa (particularly in contact‑lens wearers), Staphylococcus aureus, Streptococcus pneumoniae, and Moraxella spp.
• Viral – primarily Herpes simplex virus (HSV) and Varicella‑zoster virus (VZV). HSV keratitis is the leading cause of corneal blindness in developed nations.
• Fungal – Fusarium, Aspergillus, and Candida species are common after ocular trauma with vegetative material.
• Parasitic – Acanthamoeba spp., often linked to contaminated water or improper lens cleaning.

Key risk factors

1. Contact lens misuse – overnight wear, poor cleaning solution, expired lenses.
2. Eye trauma – scratches, foreign bodies, chemical exposure.
3. Pre‑existing ocular surface disease – dry eye, meibomian gland dysfunction, blepharitis.
4. Systemic diseases – diabetes, autoimmune disorders, HIV/AIDS.
5. Immunosuppressive therapy – topical or systemic steroids, chemotherapy.
6. Environmental exposure – farming, gardening, swimming in lakes or hot tubs.

Diagnosis

Timely diagnosis is critical. An ophthalmologist will perform a step‑by‑step evaluation:

• History & physical exam – detailed questioning about lens wear, trauma, systemic health, and symptom timeline.
• Visual acuity testing – to document baseline vision.
• Slit‑lamp biomicroscopy – allows magnified inspection of the cornea, revealing ulcer size, depth, infiltrate pattern, and presence of hypopyon (pus in the anterior chamber).
• Fluorescein staining – a dye that highlights corneal epithelial defects; the ulcer will appear as a bright green area under blue light.
• Microbiological sampling –
  • Corneal scraping for Gram stain, KOH mount, and culture on agar plates (bacterial, fungal, and Acanthamoeba media).
  • Polymerase chain reaction (PCR) for viral DNA (HSV, VZV) if viral keratitis is suspected.
• Confocal microscopy – non‑invasive imaging useful for detecting Acanthamoeba cysts and fungal filaments.
• Anterior segment optical coherence tomography (AS‑OCT) – provides cross‑sectional images to assess ulcer depth.

Treatment Options

General principles

• Initiate empiric antimicrobial therapy promptly—often before culture results return.
• Tailor treatment once the offending organism is identified.
• Avoid corticosteroids until the infection is under control (exception: HSV keratitis where steroids are used with antivirals).

Medication categories

1. Topical antibiotics (bacterial keratitis):
   • Fluoroquinolones (e.g., moxifloxacin 0.5% q.i.d.) – first‑line for contact‑lens‑related cases.
   • Broad‑spectrum fortified antibiotics (e.g., vancomycin 5% + tobramycin 1.5%) for severe or resistant infections.
2. Topical antivirals (HSV/VZV keratitis):
   • Trifluridine 1% drops q.i.d. or acyclovir 3% ointment five times daily.
   • Oral acyclovir 400 mg five times daily for stromal disease.
3. Topical antifungals (fungal keratitis):
   • Natamycin 5% suspension q.i.d. – FDA‑approved for filamentous fungi.
   • Voriconazole 1% drops q.i.d. – for deeper infections or resistant strains.
4. Anti‑Acanthamoeba agents:
   • PHMB (polyhexamethylene biguanide) 0.02% or chlorhexidine 0.04% hourly, then tapered over weeks.
   • Combination therapy with propamidine isethionate may improve outcomes.
5. Adjunctive oral therapy:
   • Oral fluoroquinolones (e.g., levofloxacin) for severe bacterial keratitis, especially when the ulcer is deep.
   • Oral antifungals (itraconazole, voriconazole) for invasive fungal disease.

Procedural interventions

• Therapeutic corneal debridement – removal of necrotic tissue to improve drug penetration.
• Anterior chamber washout – in cases with a hypopyon or refractory infection.
• Collagen cross‑linking (CXL) – emerging adjunct for early fungal or Acanthamoeba keratitis.
• Penetrating keratoplasty (corneal transplant) – reserved for perforation, scarring that threatens vision, or non‑responsive ulcers.

Lifestyle and supportive care

• Frequent lubrication with preservative‑free artificial tears to reduce epithelial stress.
• Cold compresses for pain and swelling (avoid direct pressure).
• Strict avoidance of contact lens wear until cleared by an eye‑care professional.
• Systemic control of diabetes or other co‑morbidities that impair healing.

Living with Infectious Keratitis

Daily management tips

• Medication adherence – use the exact dosing schedule; set alarms or use a pill‑tracker app.
• Eye protection – wear sunglasses outdoors to limit UV‑induced photophobia.
• Hygiene – wash hands before applying drops; avoid touching or rubbing the eye.
• Follow‑up schedule – most patients need daily visits initially, then weekly until the ulcer fully epithelializes.
• Activity modification – limit screen time, avoid dusty or smoky environments, and skip swimming until the eye is healed.
• Nutrition – diets rich in omega‑3 fatty acids (e.g., fish, flaxseed) may support corneal healing.

Impact on vision and work

While many people recover with minimal residual defect, some develop stromal scarring that reduces visual acuity. Early discussion with an occupational therapist or low‑vision specialist can help adjust work duties, especially for tasks requiring precise visual acuity (e.g., driving, operating machinery).

Prevention

• Contact lens safety
  • Always wash hands with soap before handling lenses.
  • Use only the cleaning solution recommended by your eye‑care provider—never reuse or top‑up old solution.
  • Replace lenses and cases as directed (usually every 1–3 months).
  • Avoid sleeping, swimming, or showering in lenses unless approved for extended wear.
• Protective eyewear during gardening, woodworking, or sports to prevent trauma.
• Prompt treatment of corneal injuries – rinse any foreign body with sterile saline and seek care.
• Control systemic disease – maintain glycemic control in diabetes and manage autoimmune conditions.
• Regular eye examinations – especially for high‑risk individuals (lens wearers, history of ocular surface disease).

Complications

If untreated or inadequately treated, infectious keratitis can lead to serious sequelae:

• Corneal perforation – emergency situation that may require a surgical graft.
• Irreversible scarring – can cause permanent visual loss, requiring later keratoplasty.
• Endophthalmitis – infection spreads to the interior of the eye, threatening both vision and the globe.
• Secondary glaucoma – inflammation increases intra‑ocular pressure.
• Persistent epithelial defect – delays healing and heightens infection risk.

When to Seek Emergency Care

References

• Centers for Disease Control and Prevention. “Contact Lens–Associated Eye Infections.” 2022.
• World Health Organization. “Global Initiative for the Elimination of Corneal Blindness.” 2021.
• Mayo Clinic. “Keratitis.” Updated 2023.
• Cleveland Clinic. “Infectious Keratitis: Symptoms, Diagnosis, and Treatment.” 2024.
• American Academy of Ophthalmology. Preferred Practice Pattern: Infectious Keratitis. 2022.
• J. H. Chang et al., “Management of Bacterial Keratitis: A Systematic Review,” *Ophthalmology*, 2021.

```